116 related articles for article (PubMed ID: 1902399)
1. A study of cytokine production in acute graft-vs-host disease.
Smith SR; Terminelli C; Kenworthy-Bott L; Phillips DL
Cell Immunol; 1991 May; 134(2):336-48. PubMed ID: 1902399
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of graft-versus-host disease by interleukin-2 treatment is associated with altered cytokine production by expanded graft-versus-host-reactive CD4+ helper cells.
Wang MG; Szebeni J; Pearson DA; Szot GL; Sykes M
Transplantation; 1995 Sep; 60(5):481-90. PubMed ID: 7676498
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of recombinant human interleukin 10 on disease manifestations in a P-->F1 model of acute graft versus host disease.
Smith SR; Terminelli C; Pennline KJ; Kenworthy-Bott L; Donkin J; Calzetta A
Transplantation; 1995 Mar; 59(6):890-6. PubMed ID: 7701586
[TBL] [Abstract][Full Text] [Related]
4. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
Murphy WJ; Welniak LA; Taub DD; Wiltrout RH; Taylor PA; Vallera DA; Kopf M; Young H; Longo DL; Blazar BR
J Clin Invest; 1998 Nov; 102(9):1742-8. PubMed ID: 9802888
[TBL] [Abstract][Full Text] [Related]
6. Nonspecific stimulation of host defense by Corynebacterium kutscheri. III. Enhanced cytokine induction by the active moiety of C. kutscheri.
Kita E; Kamikaidou N; Oku D; Nakano A; Katsui N; Kashiba S
Nat Immun; 1992; 11(1):46-55. PubMed ID: 1611281
[TBL] [Abstract][Full Text] [Related]
7. Enhanced interferon-alpha/beta (IFN-alpha/beta) and defective IFN-gamma production in chronic graft versus host disease: a potential mechanism for immunosuppression.
Cleveland MG; Lane RG; Klimpel GR
Cell Immunol; 1987 Nov; 110(1):120-30. PubMed ID: 3119228
[TBL] [Abstract][Full Text] [Related]
8. In vivo and in vitro cocaine modulation on production of cytokines in C57BL/6 mice.
Wang Y; Huang DS; Watson RR
Life Sci; 1994; 54(6):401-11. PubMed ID: 8295487
[TBL] [Abstract][Full Text] [Related]
9. Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease.
Nestel FP; Price KS; Seemayer TA; Lapp WS
J Exp Med; 1992 Feb; 175(2):405-13. PubMed ID: 1732411
[TBL] [Abstract][Full Text] [Related]
10. Production of cytokines after lipopolysaccharide stimulation of murine spleen cells during lymphoma development in AKR mice.
Vaillier D; Daculsi R; Legrand E; Guillemain B
Cancer Immunol Immunother; 1989; 29(1):35-42. PubMed ID: 2468413
[TBL] [Abstract][Full Text] [Related]
11. TNF enhances CD4+ T cell alloproliferation, IFN-gamma responses, and intestinal graft-versus-host disease by IL-12-independent mechanisms.
Brown GR; Lee EL; Thiele DL
J Immunol; 2003 May; 170(10):5082-8. PubMed ID: 12734353
[TBL] [Abstract][Full Text] [Related]
12. In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease.
Cleveland MG; Annable CR; Klimpel GR
J Immunol; 1988 Nov; 141(10):3349-56. PubMed ID: 3141498
[TBL] [Abstract][Full Text] [Related]
13. Effects of in vivo administration of interferon (IFN)-gamma, anti-IFN-gamma, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease.
Umland SP; Razac S; Nahrebne DK; Seymour BW
Clin Immunol Immunopathol; 1992 Apr; 63(1):66-73. PubMed ID: 1591885
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 and interleukin-2 defects associated with murine graft-versus-host-induced immunodeficiency.
Mendes ML; Rode H; Peres A; Kongshavn PA; Lapp WS
Transplantation; 1985 Apr; 39(4):418-24. PubMed ID: 3872492
[TBL] [Abstract][Full Text] [Related]
15. Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.
Giese NA; Gazzinelli RT; Actor JK; Morawetz RA; Sarzotti M; Morse HC
Immunology; 1996 Mar; 87(3):467-74. PubMed ID: 8778035
[TBL] [Abstract][Full Text] [Related]
16. Depletion of natural killer cells from the graft reduces interferon-gamma levels and lipopolysaccharide-induced tumor necrosis factor-alpha release in F1 hybrid mice with acute graft-versus-host disease.
Ellison CA; HayGlass KT; Fischer JM; Rector ES; MacDonald GC; Gartner JG
Transplantation; 1998 Aug; 66(3):284-94. PubMed ID: 9721794
[TBL] [Abstract][Full Text] [Related]
17. Gene expression and production of tumor necrosis factor alpha, interleukin 1, interleukin 6, and gamma interferon in C3H/HeN and C57BL/6N mice in acute Mycoplasma pulmonis disease.
Faulkner CB; Simecka JW; Davidson MK; Davis JK; Schoeb TR; Lindsey JR; Everson MP
Infect Immun; 1995 Oct; 63(10):4084-90. PubMed ID: 7558323
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
Akarid K; Pocidalo MA; Desforges B; Sinet M
Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum.
Smith SR; Calzetta A; Bankowski J; Kenworthy-Bott L; Terminelli C
J Leukoc Biol; 1993 Jul; 54(1):23-9. PubMed ID: 8336076
[TBL] [Abstract][Full Text] [Related]
20. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection.
O'Sullivan ST; Lederer JA; Horgan AF; Chin DH; Mannick JA; Rodrick ML
Ann Surg; 1995 Oct; 222(4):482-90; discussion 490-2. PubMed ID: 7574928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
